Dermatologist's Take
Hydroxypinacolone retinoate, or HPR, is a retinoid — chemically, retinoic acid with a chemical group attached. Two things are worth knowing before anything else. First, the label arithmetic: "Granactive Retinoid" is a trade name for a supplied solution that is about 10% HPR, so a product advertising "Granactive Retinoid 2%" contains roughly 0.2% HPR, not 2%. Second, the evidence: there is no published, independent trial of HPR on its own against a placebo or against another retinoid. Every human study puts it in a formula with other actives, or was run by the company selling it, or both. What is genuinely well established, by independent university researchers with no commercial stake, is that HPR is the most chemically stable of the common cosmetic retinoids. That is a real advantage — but it is a formulation advantage, not a clinical one. If you want a gentler retinoid that has actually been studied, retinaldehyde has considerably more human data behind it.
At a glance
- AKA HPR, Granactive Retinoid (a supplier trade name, not the ingredient name)
- Typically 0.1–0.5% actual HPR. A "2%" label usually means about 0.2%
- Works with niacinamide, moisturizers, sunscreen. No published interaction data
- Evidence: Limited — no published trial of HPR alone. Strong only on shelf stability
What is it?
Hydroxypinacolone retinoate is a laboratory-made retinoid. Structurally it is all-trans retinoic acid — the prescription molecule, tretinoin — with a chemical group called hydroxypinacolone attached to it, forming what chemists call an ester.
That matters in theory. Retinol has to be converted twice inside the skin before it becomes retinoic acid, the form that actually does the work. HPR is already at the retinoic acid stage, chemically speaking. The marketing claim is that it therefore works without needing conversion, binding retinoid receptors directly.
That claim has never been published. It comes from the supplier's own literature. No paper reports HPR's binding at retinoid receptors, and nobody has published what happens to the molecule once it is in human skin. It is a chemically reasonable idea that has not been tested — and there is an awkward logic in it either way. If HPR is broken down to retinoic acid in the skin, it is effectively a tretinoin delivery system and would be expected to irritate. If it is not broken down, then no one has shown that the intact molecule binds anything.
How it works
The honest answer is that nobody has published how HPR works in human skin.
Retinoids in general work by binding retinoic acid receptors inside skin cells, which changes which genes are switched on — more collagen, faster turnover of the outer layer, less pigment production. That pathway is mapped in detail for retinoic acid and understood well for retinol.
For HPR specifically, three things are missing from the published literature: a receptor-binding study, a study of what the molecule turns into in skin, and a trial of HPR on its own. The mechanism described on product pages is a supplier assertion, repeated widely enough that it now reads as established fact.
One published finding is worth noting because it complicates the picture. A study comparing five retinoids side by side in laboratory and animal models found retinyl palmitate and retinyl propionate — both usually treated as weak, entry-level retinoids — performed better than HPR. That study is rarely mentioned.
Subtypes
The naming is the single most confusing thing about this ingredient, and it is worth getting straight.
"Granactive Retinoid" is a trade name owned by the ingredient supplier, Grant Industries. What they sell is not pure HPR — it is a solution containing about 10% HPR dissolved in a solvent called dimethyl isosorbide. The supplier's own specification sheet gives the HPR content as 9.5% to 10.5%.
Brands then name their products after how much of that solution they used. So:
- "Granactive Retinoid 2%" — about 0.2% HPR, plus about 1.8% solvent.
- "Granactive Retinoid 5%" — about 0.5% HPR, plus about 4.5% solvent.
Neither figure is disclosed by the brands themselves; it comes from the supplier's specification. This is not a scandal — nobody is hiding anything, and the trade name is used consistently. But a shopper comparing "2% Granactive Retinoid" with "0.5% retinol" is not comparing what they think they are comparing.
A further wrinkle: the supplier sells more than one Granactive material, including an encapsulated powder version with a different composition. "Granactive Retinoid" on a label is not one fixed thing.
Concentrations
Finished products typically contain 0.1% to 0.5% actual HPR, though most do not state it.
There is no way to compare that meaningfully against a retinol percentage, and anyone who gives you a conversion — "0.2% HPR is like 0.5% retinol" or "equivalent to 0.025% tretinoin" — has invented it. No published study has measured HPR's potency against another retinoid at matched doses. That work simply has not been done.
Nor does the supplier publish a recommended use level in its public documents. Any specific "use at X%" figure circulating online should be treated as unverified.
What can be said: 0.5% HPR contains two and a half times as much of the ingredient as 0.2%. Whether that produces more benefit, more irritation, or neither has never been tested.
Conditions it treats
What to expect
Because no trial has tested HPR by itself, there is no evidence-based timeline. Retinoids in general take 12 weeks or more, and there is no reason to expect HPR to be faster.
On tolerability, be careful with the "non-irritating" claim. It originates from the supplier's own unpublished panel testing, with no sample sizes, durations or methods given.
The published human data are mixed. In a 98-person acne study of a gel containing 0.1% HPR alongside retinol and papain, 15% of people reported dryness, peeling, redness or burning. On the other side, a manufacturer-run 24-hour patch test found an HPR combination gentler than retinol at the same concentration. And several 2024–2026 formulation papers were undertaken specifically to reduce HPR's irritation and cell toxicity — which rather implies free HPR is not inert.
There is no published head-to-head tolerability trial of HPR against retinol at comparable doses.
As with any retinoid, wear sunscreen. Nobody has studied whether HPR affects sun sensitivity either way.
The evidence2 studies
Studies behind the treatments above. Tap any tag to see what it means.
Hydroxypinacolone retinoate was the most stable of sixteen retinoid derivatives tested across twelve commercial products, under real-time, accelerated and light-exposure conditions.
Moderate evidence
An independent university analytical study with no commercial funding, which is rare in this ingredient's literature. Graded moderate rather than strong because it measures what happens in the container, not what happens on skin.
Laboratory analysis
Chemical stability testing of commercial products, not a clinical trial. It tells you whether the ingredient survives in the bottle, not whether it works on skin.
A gel with 0.1% HPR, retinol and papain reduced acne lesions by about 41% over 12 weeks — but 15% of users reported dryness, peeling, redness or burning.
Limited evidence
Open-label with no control group and no blinding, so there is nothing to compare against and improvement over twelve weeks could reflect the natural course as much as the treatment. The authors themselves state that a controlled study is needed.
94 people
How many people took part. Bigger studies are less likely to show a result by chance alone.
Three actives in one gel
The gel contained retinol and papain alongside HPR. Nothing in the result can be attributed to HPR specifically.
Veraldi, Giornale Italiano di Dermatologia e Venereologia 2015 →